ArticleEuropean urology2020

Reply to Torgrim Tandstad. The New Standard Adjuvant Treatment for High-risk Stage 1 Nonseminoma: Reducing the Treatment Burden and Maximizing Long-term Survival. Eur Urol 2020;77:352-3.

Robert Huddart et al.PubMed ↗Publisher ↗

No numbers read from the abstract.